Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Times Leader
Click for weather forecast
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Akebia Therapeutics
(NQ:
AKBA
)
3.050
USD
-0.120 (-3.79%)
Official Closing Price
Updated: 6:50 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Akebia Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Akebia Therapeutics to Present at H.C. Wainwright Bioconnect 2021 Conference
January 06, 2021
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, President and Chief...
From
PR Newswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2021
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase...
From
PR Newswire
Akebia Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, President and Chief...
From
PR Newswire
Peek Under The Hood: IEIH Has 17% Upside
December 30, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
3 Top Penny Stocks On Robinhood To Buy Under $3.50
December 14, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
AkebiaShares Program: Current Approaches for Managing Hyperphosphatemia and Caring for Patients via Telehealth
December 09, 2020
Virtual Panel of Nephrology Care Professionals to Share Insights and Experiences Managing Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
From
PR Newswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 7 newly-hired employees options to purchase an...
From
PR Newswire
Interesting AKBA Put And Call Options For July 2021
December 02, 2020
Investors in Akebia Therapeutics Inc (AKBA) saw new options become available this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,...
Tags
Stocks
From
Market News Video
Top Penny Stocks To Watch Today; 4 With 75%-233% Price Targets
November 30, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Akebia Therapeutics to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
November 24, 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will participate in the Piper...
From
PR Newswire
68 Biggest Movers From Yesterday
November 20, 2020
Gainers Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) gained 157.9% to close at $49.00 after the company priced its IPO at $19 per ...
Tags
MDGS
Top Gainers
Information Technology
From
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
November 19, 2020
Gainers Naked Brand Group Limited (NASDAQ: NAKD) shares jumped 77.7% to $0.2302 after jumping around 47% on Wednesday. Phoenix ...
Tags
FIII
CIIC
FENG
From
Benzinga
34 Stocks Moving in Thursday's Pre-Market Session
November 19, 2020
Gainers Hudson Capital Inc. (NASDAQ: HUSN) shares rose 44.2% to $3.23 in pre-market trading. Hudson Capital, on Monday, said it ...
Tags
AKBA
GPRO
Markets
From
Benzinga
5 Best Penny Stocks Today If Biotech Stocks Are Your Focus
November 18, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Akebia Therapeutics Ranked 10th Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™
November 18, 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it ranked number 10 on Deloitte's...
From
PR Newswire
Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
November 17, 2020
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most ...
Tags
Greenlight Capital
MSI
BMY
From
Benzinga
Akebia Announces Manuscript Highlighting Global Phase 3 INNO2VATE Program Rationale, Study Design and Baseline Characteristics Published in Peer-Reviewed Medical Journal
November 16, 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the publication of a manuscript...
From
PR Newswire
Akebia Reports Third Quarter 2020 Financial Results and Recent Business Updates
November 05, 2020
- Presented positive global Phase 3 data for vadadustat from the INNO2VATE program for the treatment of anemia due to chronic kidney disease in adult patients on dialysis at ASN Kidney Week
From
PR Newswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 6 newly-hired employees options to purchase an...
From
PR Newswire
Stocks That Hit 52-Week Lows On Friday
October 30, 2020
Friday's morning session saw 24 companies set new 52-week lows. Significant Points: Walgreens Boots Alliance ...
Tags
Trading Ideas
SNDL
JAGX
From
Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
BCDA
UTHR
AXGN
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 29, 2020
Before 10 a.m. ET Thursday, 104 stocks made new 52-week lows. Highlights: Wells Fargo (NYSE: WFC) was the largest ...
Tags
SFL
PDM
NRBO
From
Benzinga
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
OPK
ZSAN
MRK
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 28, 2020
During Wednesday's morning trading, 129 companies set new 52-week lows. Areas of Interest: The largest company in terms of ...
Tags
SEAC
DBVT
HAPP
From
Benzinga
52 Biggest Movers From Yesterday
October 28, 2020
Gainers Scholar Rock Holding Corporation (NASDAQ: SRRK) shares jumped 118.8% to close at $30.02 on Tuesday after the company ...
Tags
CHGG
TC
KBSF
From
Benzinga
Akebia Therapeutics to Report Third Quarter 2020 Financial Results and Discuss Recent Business Highlights
October 26, 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results...
From
PR Newswire
Akebia Presents Results from its PRO2TECT Global Phase 3 Program of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients Not on Dialysis During Late-Breaking Session
October 23, 2020
- As previously announced, PRO2TECT data show vadadustat achieved primary and key secondary efficacy endpoints in each study, but did not meet the primary safety endpoint
From
PR Newswire
The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO
October 23, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IBB
Trading Ideas
BIO
From
Benzinga
5 Penny Stocks To Watch After Gilead Sciences’ Big Remdesivir News
October 22, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Akebia Presents Results from its INNO2VATE Global Phase 3 Program; Demonstrated Efficacy and Cardiovascular Safety of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Pati
October 22, 2020
- INNO2VATE data presented at American Society of Nephrology Kidney Week 2020 Reimagined
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.